Dr Marc Hübner is the coordinator of the EU-funded eWHORM EDCTP3 project, designed to provide the proof of concept in an adaptive phase 2 clinical trial with oxfendazole as pan-nematode drug candidate for the filarial diseases onchocerciasis, loiasis and mansonellosis as well as the soil-transmitted, intestinal helminth disease trichuriasis. This study takes place in Gabon, Cameroon, DRC and Tanzania.
Since 2020, he is the head of diagnostics in parasitology at the IMMIP and W2 Professor for translational microbiology. Among his professional functions, he works as INSTAND QA scheme consultant, chair of the German Society for Parasitology and board member of the German Society of Tropical Medicine, Travel Medicine and Global Health.
